Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
ArsenalBio halves staff amid reorganization efforts
The shift to a clinical focus does not impact the Bay Area biotech’s long-standing collaboration with BMS, an ArsenalBio spokesperson said.
Darren Incorvaia
Sep 17, 2025 4:55pm
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Aug 27, 2025 8:10am
Cell therapy biotech Appia shuts down as funding runs dry
Aug 25, 2025 5:55pm
Kite sails into in vivo CAR-T space via $350M Interius buyout
Aug 21, 2025 9:59am
Allogene reports patient death tied to mAb in CAR-T pivotal trial
Aug 1, 2025 8:30am
AstraZeneca drops lead TCR therapy from $200M Neogene buy
Jul 29, 2025 4:13am
